Man Group plc lessened its position in shares of DocuSign, Inc. (NASDAQ:DOCU - Free Report) by 54.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 184,204 shares of the company's stock after selling 216,937 shares during the period. Man Group plc owned approximately 0.09% of DocuSign worth $16,567,000 at the end of the most recent quarter.
Other institutional investors also recently made changes to their positions in the company. FMR LLC lifted its stake in DocuSign by 178.2% during the fourth quarter. FMR LLC now owns 6,101,024 shares of the company's stock worth $548,726,000 after purchasing an additional 3,908,139 shares during the last quarter. American Century Companies Inc. boosted its position in shares of DocuSign by 18.5% during the 4th quarter. American Century Companies Inc. now owns 5,315,459 shares of the company's stock worth $478,072,000 after purchasing an additional 831,611 shares in the last quarter. Jericho Capital Asset Management L.P. lifted its position in DocuSign by 34.0% in the 4th quarter. Jericho Capital Asset Management L.P. now owns 4,754,753 shares of the company's stock valued at $427,642,000 after acquiring an additional 1,205,500 shares in the last quarter. Renaissance Technologies LLC grew its stake in DocuSign by 4.9% in the 4th quarter. Renaissance Technologies LLC now owns 4,363,292 shares of the company's stock valued at $392,434,000 after buying an additional 205,304 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in DocuSign by 7.2% in the 4th quarter. Geode Capital Management LLC now owns 3,732,363 shares of the company's stock valued at $335,147,000 after purchasing an additional 249,179 shares during the period. Institutional investors own 77.64% of the company's stock.
DocuSign Stock Performance
Shares of NASDAQ:DOCU traded down $1.58 during trading hours on Tuesday, hitting $89.73. 2,052,729 shares of the company's stock traded hands, compared to its average volume of 2,760,831. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86. The company's fifty day simple moving average is $81.41 and its two-hundred day simple moving average is $85.45. The company has a market cap of $18.17 billion, a price-to-earnings ratio of 18.50, a price-to-earnings-growth ratio of 6.94 and a beta of 1.21.
DocuSign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings results on Thursday, March 13th. The company reported $0.86 EPS for the quarter, beating the consensus estimate of $0.84 by $0.02. The company had revenue of $776.25 million for the quarter, compared to the consensus estimate of $760.94 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The company's revenue for the quarter was up 9.0% compared to the same quarter last year. During the same quarter last year, the company posted $0.76 earnings per share. On average, analysts anticipate that DocuSign, Inc. will post 1.17 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
DOCU has been the subject of several recent research reports. UBS Group lowered their price target on shares of DocuSign from $90.00 to $85.00 and set a "neutral" rating for the company in a research note on Thursday, April 17th. Morgan Stanley dropped their target price on shares of DocuSign from $97.00 to $92.00 and set an "equal weight" rating on the stock in a report on Wednesday, April 16th. Bank of America decreased their price target on shares of DocuSign from $112.00 to $98.00 and set a "neutral" rating on the stock in a research report on Friday, March 14th. Needham & Company LLC reaffirmed a "hold" rating on shares of DocuSign in a research note on Thursday, April 17th. Finally, JMP Securities reiterated a "market outperform" rating and issued a $124.00 price target on shares of DocuSign in a report on Thursday, April 17th. One analyst has rated the stock with a sell rating, eleven have issued a hold rating and four have assigned a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus target price of $92.46.
Check Out Our Latest Analysis on DOCU
Insider Transactions at DocuSign
In related news, Director Teresa Briggs sold 534 shares of the business's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $87.41, for a total transaction of $46,676.94. Following the transaction, the director now directly owns 8,270 shares of the company's stock, valued at approximately $722,880.70. The trade was a 6.07% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Blake Jeffrey Grayson sold 16,111 shares of the company's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $83.20, for a total value of $1,340,435.20. Following the sale, the chief financial officer now owns 93,960 shares of the company's stock, valued at approximately $7,817,472. The trade was a 14.64% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 47,851 shares of company stock worth $3,912,239. 1.01% of the stock is currently owned by company insiders.
DocuSign Profile
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
See Also

Before you consider DocuSign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.
While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report